← Back
$CVKD All transactions

Cadrenal Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$12K

Shares

881

Price

$14

Filed

Oct 1

Insider

Name

Pham Quang X

Title

CEO and Chairman

CIK

0001405290

Roles

Director Officer 10% Owner

Transaction Details

Transaction Date

2025-10-01

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

202,633

Footnotes

Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement in multiple transactions at prices ranging from $13.99 through $14.02, inclusive, having a weighted average price as shown in column 4 of $14.01. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. | Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement in multiple transactions at prices ranging from $13.99 through $14.05, inclusive, having a weighted average price as shown in column 4 of $14.01. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. | Quang Pham is the Trustee of The PVBQ Living Trust and has sole voting and disposition power with respect to the shares owned by The PVBQ Trust, of which Mr. Pham's child is the sole beneficiary.

Filing Info

Accession No.

0001213900-25-094803

Form Type

4

Issuer CIK

0001937993

Pham Quang X's History

Date Ticker Type Value
2025-10-27 CVKD $18K
2025-10-24 CVKD $16K
2025-10-13 CVKD $25K
2025-10-09 CVKD $25K
2025-10-02 CVKD $7K
2025-10-01 CVKD $12K
2025-09-29 CVKD $6K
2025-09-25 CVKD $96K
2025-09-24 CVKD $36K
2025-08-28 CVKD $17K

Other Insiders at CVKD (90d)

No other insider activity at this issuer in the last 90 days.